A critical advance in cancer research is occurring with the use of VHH fragments to reactivate damaged p53. This essential cancer suppressor protein is frequently inactivated in several forms of tumors, causing https://bookmarks4seo.com/story21988478/mini-antibodies-reactivate-tumor-suppressor-p53-the-promising-pathway-for-tumor-management